Danny Yeung and David Beckham’s IM8 is shaking up the supplements industry

For the last year or so, there’s been a sleek, red, octagonal vessel seeking pride of place on your supplements shelf, targeted at replacing all your daily veggie caps in one aesthetically pleasing fell swoop. It’s called IM8, and it is the biggest disrupter the supplements industry has seen in a long time: an all-in-one powdered product that mixes with water to deliver a blend of 92 ingredients at clinically effective dosages designed to boost your health – from vitamins and minerals to adaptogens, probiotics, electrolytes and amino acids. What makes IM8 even more of a golden child are its credentials. Hong Kong’s Prenetics – along with a certain David Beckham – have founded a brand, IM8 Health, to market the supplement. It boasts an advisory board stacked with academics and experts from the likes of Mayo Clinic and Nasa to oversee certification and transparency, with third-party testing of all ingredients from the get-go and full details of its US manufacturer, Vitaquest. Though Prenetics built its name on DNA testing that feeds into a preventive healthcare approach and grew substantially during Covid by meeting a market opportunity for Covid-19 testing (at one point handling up to 40,000 tests per day), its co-founder, Danny Yeung, has his focus almost entirely on IM8 these days. A serial entrepreneur raised in California’s Bay Area, Yeung started out as a telemarketer at just 15 years old. Later, aged 24, he cold-called Hui Lau Shan, franchising the Chinese fruit desserts shop for the San Francisco market. He has also had a furniture export business servicing hotels, and before launching Prenetics, moved to Hong Kong to spearhead a group-buy platform that he eventually sold to Groupon. But while his philosophy has largely been to build it and sell it, there’s something about IM8 that is keeping him hooked. “It’s in my personality. I love learning new things – to research, read about it, know all the ins and outs of the industry, talk to industry experts,” says Yeung. “I like the act of product creation. And I like to see the journey from zero to one, because I think that in business, that is actually the most difficult. Once you’ve already got to one, the next step, from one to 10, is actually much easier. “But now … with what I’ve seen in terms of our growth trajectory, I want to take this from one to 10, which is a unique opportunity for myself, the team and our investors and partners – like David Beckham and Aryna Sabalenka [the world No 1 tennis player who became an investor-partner after using and becoming a fan of the product].” With the interplay of wellness and longevity becoming only ever more important to people across the world, Yeung notes that creating IM8 was perhaps fuelled by insights that he had from running Prenetics for the last 10 years or so, but that it was also simply a case of understanding the problem and then going out and solving it. “Actually, everyone told me not to get into [the supplements industry],” he says. The low barriers to entry meant that the market was already supersaturated, but with many of the suppliers and brands ultimately lacking credibility and ethics. “There must be a way that we can create trust and credibility,” he points out. “Think about clinical trials, right? Third-party testing. We even put our manufacturers online, so you can literally go there and just copy [our whole formula]. But we wanted to create a brand that withstood the test of time, and so it had to be about more than just David Beckham. A lot of people say, ‘Oh, wow, you got David Beckham, then you don’t have to do anything.’ It’s actually far from the truth. When you have someone like David, you actually have to do more, because you’re going to be much more scrutinised. I promised him: ‘You know, we do this together, I guarantee it’ll be the best product on the market. And every product that follows, we will also have that type of philosophy.’” The company isn’t just responsive to its co-founder’s needs. If there’s one thing that Yeung knows, it’s data, and the company collects feedback frequently to drive decisions. Within a few months, the brand responded to customers who travel frequently and didn’t want to carry a month’s supply in their suitcase by allowing free “upgrades” to single-serve packages. Within a year, it has already replaced its longevity pill with a new powdered supplement. It’s a pivot-fast model that Yeung suggests may be controversial because it necessitates a very lean team, with little bureaucracy and high accountability. Perhaps equally unconventional is Yeung’s confession that he has few, if any, hobbies, and that his passion for work is singular and all-consuming. “Let’s say I go to a restaurant. I would observe how they work with the menu, how they justify their price point. I’m always observing and talking to different people, and then you always get new inspiration about how we can do this or add that,” he says. It is perhaps this attitude – seeing the world as one big case study – that led Yeung to gamble on turning IM8’s US$100-plus million annualised recurring revenue into a bitcoin treasury. In December 2025, Prenetics ended this strategy, stating that it would now focus its capital allocation on the “growth, operations and strategic expansion of IM8”. This bold approach to financing is laid out in a 32-page manifesto that is an hour’s worth of reading, penned by Yeung and featured on Prenetics’ website. “I think it’s about doing things that are unconventional. You have to be taking bold bets,” he says. “We already announced a few weeks ago that we’re now focusing on removing non-core assets. Moving forward, it’s just going to be IM8 and bitcoin. A lot of the other stuff we’re looking [to divest]. But if we’re successful in this convergence of health and wealth, then I think that would be something that is like, ‘Oh, wow, you really put health and wealth together.’” This all-consuming focus means that Yeung’s mind is constantly working. “There’s always something to do,” he admits. While some founders might relax after hitting it big, Yeung can’t help but throw himself further into the project. “This is a very unique opportunity. … Now is the time to really double down on this, rather than to take the foot off the gas.” The journey from one to 10 is just beginning.

Danny Yeung and David Beckham’s IM8 is shaking up the supplements industry

.css-1c6uqr6{color:inherit;font-weight:inherit;font-size:inherit;font-family:inherit;line-height:inherit;overflow-wrap:break-word;}Developed by Hong Kong’s Prenetics and the former footballer, IM8 emphasises transparency and third-party testing with its 92‑ingredient formula

Developed by Hong Kong’s Prenetics and the former footballer, IM8 emphasises transparency and third-party testing with its 92‑ingredient formula